In this analysis, Frost & Sullivan identifies and defines the leading megatrends shaping the global pharmaceutical landscape. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and the Middle East and Africa. Small molecules and large molecules are the 2 major segments covered. The subsegments are monoclonal antibodies, vaccines, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) therapeutics, cell and gene therapies, protein and peptide therapies, small molecule chemistry, plasma-derived therapies, and others.

• What are the key growth prospects across major segments and subsegments in the pharmaceutical industry?
  
• Which macroeconomic megatrends are driving the future of the pharma landscape?
  
• How will R&D expenditure and leading therapeutic areas influence the growth potential of pharmaceuticals?